This content is machine translated Chronic kidney disease (CKD) Triage of high-risk patients – Update 2025 In the recent past, the nephroprotective treatment armamentarium has been significantly expanded. It is essential that impaired renal function is detected in good time in order for patients to receive...…
View Post 3 min This content is machine translated AAD Annual Meeting: Review HS and acne – what’s new? In addition to the question of how to classify the latest test results on benzoyl peroxide (BPO) preparations used in acne treatment, the results of clinical studies on bimekizumab and...…
View Post 6 min This content is machine translated Treatment of vitiligo Focus on patient perspective and disease activity In vitiligo, hypopigmented or depigmented areas of skin occur as a result of an autoimmune disorder. The results of a large international survey confirm that vitiligo sufferers sometimes experience considerable...…
View Post 5 min This content is machine translated Vaccine-preventable respiratory diseases RSV and pneumococci: recommendations for risk groups In addition to the known risks of respiratory syncytial virus (RSV) infections in newborns, infants and young children, it has recently emerged thatS RSV also poses significant health risks for...…
View Post 4 min This content is machine translated New practice guideline for fibromyalgia syndrome Good times, bad times Patients with fibromyalgia syndrome (FMS) have comparatively low muscle strength in the static and moving muscles. The most important thing is therefore to get patients moving. Regular exercise has been...…
View Post 8 min This content is machine translated Chronic inducible urticaria What has stayed the same, what has changed? Over the past decades, significant progress has been made in understanding the pathogenesis of chronic inducible urticaria (CIndU). Provocation tests continue to play an important role in confirming the diagnosis....…
View Post 5 min This content is machine translated Paroxysmal nocturnal hemoglobinuria Real-world data on thrombosis predictors and C5 complement inhibitors Paroxysmal nocturnal haemoglobinuria (PNH) is a rare, acquired disease of haematopoietic stem cells of the bone marrow. GPI deficiency results in the absence of complement-regulating proteins. Thromboembolic complications are the...…
View Post 5 min This content is machine translated Glomerulonephritis: IgA nephropathy Pathogenesis-based and nephroprotective therapeutic approaches Immunoglobulin (Ig) A nephropathy is considered an important cause of end-stage renal failure. Therefore, from today’s perspective, IgA nephropathy should not be classified as a benign disease. Fortunately, the treatment...…
View Post 4 min This content is machine translated Current findings on myelofibrosis Reduce anemia and transfusion dependency Myelofibrosis (MF) is a rare clonal disease of pluripotent hematopoietic stem and progenitor cells. There have been significant advances in the treatment options for MF in recent years, but anemia...…
View Post 6 min This content is machine translated Postmenopausal osteoporosis: long-term therapy concepts Targeted use of antiresorptives and osteoanabolic agents and avoid “rebound” effects Postmenopausal osteoporosis in women is a consequence of decreasing oestrogen levels and is associated with rapid bone loss (“high-turnover osteoporosis”). Long-term therapy concepts are required to achieve sustainable effects –...…
View Post 8 min This content is machine translated Atopic dermatitis Implement the “minimal disease activity” concept Minimal disease activity (MDA) in atopic dermatitis (AD) is a concept that combines a treat-to-target therapeutic strategy with the principle of shared decision-making. The aim is to achieve a state...…
